PAM
EDIT icon

Paradigm Asset Management’s Editas Medicine EDIT Stock Holding History

Paradigm Asset Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,900
Closed -$93.2K – 415
2022
Q1 		$93.2K Hold
4,900
– – 0.02% 347
2021
Q4 		$130K Sell
4,900
-600
-11% -$20.7K 0.03% 312
2021
Q3 		$226K Sell
5,500
-600
-10% -$32.9K 0.06% 299
2021
Q2 		$346K Sell
6,100
-400
-6% -$14.8K 0.09% 287
2021
Q1 		$273K Sell
6,500
-600
-8% -$34.2K 0.07% 307
2020
Q4 		$498K Buy
+7,100
New +$292K 0.14% 253

Other funds holding EDIT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Paradigm Asset Management's EDIT Position: Q2 2022 in Review

Paradigm Asset Management sold out of Editas Medicine (EDIT) in Q2 2022, closing a stake of 4,900 shares — an estimated $93.2K sold.

Paradigm Asset Management first reported a position in EDIT in Q4 2020 and held it in 6 quarters. The position peaked at $498K in Q4 2020. 256 funds tracked by Wall St. Rank hold EDIT as of Q2 2022.

  • Paradigm Asset Management reported no remaining Editas Medicine position as of Q2 2022 after selling out during the quarter.
  • Paradigm Asset Management sold 4,900 Editas Medicine shares in Q2 2022, an estimated $93.2K.
  • Paradigm Asset Management first reported a position in Editas Medicine in Q4 2020 and held it in 6 quarters.
  • Paradigm Asset Management's Editas Medicine position peaked at $498K in Q4 2020.
  • 256 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2022.

Based on Paradigm Asset Management's 13F filing for Q2 2022, filed 8 Aug 2022.